secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001193125-25-057901
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences regains Nasdaq compliance with net income rule
--------------------------------------------------------------------

- Nasdaq Panel confirmed compliance with Listing Rule 5550(b)(3) (minimum $500K net income from continuing operations).
- Company subject to a one-year discretionary monitor; any future deficiency triggers automatic delist process.
- Prior deficiencies for Market Value of Listed Securities (<$35M) and Equity Rule are now resolved.
- Panel closed the matter; listing on Nasdaq Capital Market continues effective March 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525057901/0001193125-25-057901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525057901/d841978d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-057901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer